This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Novacell Technology Inc.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Innovations of Jong Hyuk Yoon in Collagen Synthesis
Introduction
Jong Hyuk Yoon is a notable inventor based in Pohang-si, South Korea. He has made significant contributions to the field of cosmetic and pharmaceutical compositions, particularly in the area of wound healing. His innovative work focuses on enhancing collagen synthesis in the skin, which is crucial for effective healing.
Latest Patents
Jong Hyuk Yoon holds a patent for a peptide that has the ability to synthesize collagen. The patent, titled "Peptide having ability to synthesize collagen and use thereof," describes a cosmetic and pharmaceutical composition that efficiently promotes collagen synthesis in the skin. The active ingredient in these compositions is the YIGSR peptide, which has the amino acid sequence of SEQ ID NO: 1, or a peptide derivative that includes a palmitoyl group added to the N-terminal of the peptide. This innovation is particularly valuable for wound healing applications.
Career Highlights
Jong Hyuk Yoon is associated with Novacell Technology Inc., where he continues to develop and refine his innovative ideas. His work has garnered attention for its potential impact on the cosmetic and pharmaceutical industries. With a focus on practical applications, he aims to improve skin health and healing processes through his research.
Collaborations
Jong Hyuk Yoon collaborates with talented individuals in his field, including Tae Hoon Lee and Jae Yoon Kim. These collaborations enhance the research and development efforts at Novacell Technology Inc., fostering an environment of innovation and creativity.
Conclusion
Jong Hyuk Yoon's contributions to collagen synthesis and wound healing represent a significant advancement in cosmetic and pharmaceutical sciences. His innovative approach and dedication to research continue to influence the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile